Medical Mycology – Page 3

Simultaneous infection with Fusarium proliferatum and Prototheca wickerhamii localized at different body sites

mycolabadmin

An 81-year-old woman taking long-term steroid medication developed two different fungal skin infections on her hands simultaneously – one on the right hand from a moldy wooden frame and one on the left hand possibly from sewage exposure. Doctors identified both fungi through microscopy and genetic testing. She was successfully treated with an antifungal medication called voriconazole for four weeks and recovered completely.

Molecular Identification of Candida Species among Iranian Patients: Pursuing Candida auris

mycolabadmin

Researchers in Iran studied 136 hospital patients to identify different types of Candida fungal infections using a molecular laboratory technique called PCR-RFLP. They found that while Candida albicans remained the most common species, other Candida species were increasingly prevalent in hospitalized patients. The study developed a cost-effective diagnostic method that could help developing countries identify these fungal infections faster and more accurately, though the dangerous multidrug-resistant Candida auris was not found in their samples.

Detection of Multiple Nosocomial Trichosporon asahii Transmission Events via Microsatellite Typing Assay, South America

mycolabadmin

Researchers developed a test to identify different strains of a dangerous fungus called Trichosporon asahii that causes serious infections in hospitals. Using this test on samples from South America, they discovered that multiple patients in different hospitals were infected with genetically identical strains, suggesting the fungus was spreading between patients. This typing method is faster and cheaper than other genetic tests, making it useful for hospitals in countries with limited resources to track and control fungal outbreaks.

Protein kinase A signaling regulates immune evasion by shaving and concealing fungal β-1,3-glucan

mycolabadmin

Candida albicans, a common fungal pathogen, uses a clever strategy to hide from the immune system by masking a molecule on its surface that would normally trigger an immune response. Researchers used both computer modeling and laboratory experiments to show that this hiding strategy involves two main processes: the fungus grows and exposes the molecule, while simultaneously using enzymes to shave it away. They found that a cellular signaling pathway called PKA is essential for activating these shaving enzymes in response to lactate, a signal from the host environment.

Past, present and future of antifungals: Advancements in mechanisms of action and resistance

mycolabadmin

Fungal infections are a growing global health threat, especially for people with weakened immune systems, causing millions of deaths annually. Currently available antifungal drugs are limited and increasingly face resistance, making them less effective over time. This special collection of research papers explores new approaches to treating fungal infections, including novel drugs, combination therapies, and alternative treatments to overcome resistance. Scientists and doctors hope these advances will help save more lives by providing better options for treating serious fungal diseases.

Interaction with amoeba drives virulence-associated phenotypes in the Candida haemulonii complex

mycolabadmin

Researchers discovered that when fungal pathogens called Candida haemulonii are exposed to soil amoebae in laboratory conditions, they develop enhanced disease-causing abilities. These fungi undergo multiple changes including forming stronger protective biofilms, producing more virulence factors, and becoming harder to kill by immune defenses. This suggests that fungal pathogens might develop some of their dangerous traits not from infecting humans, but from surviving in soil environments where they must evade predatory organisms like amoebae.

Phaeoacremonium tuscanicum and Phaeoacremonium indicum sp. nov. associated with subcutaneous phaeohyphomycosis

mycolabadmin

Researchers identified and described two rare fungal infections caused by Phaeoacremonium species in human patients. One case involved a previously unknown fungal species in humans called Phaeoacremonium indicum, discovered in an Indian transplant patient with a knee infection. Both cases were successfully treated with surgery, with one patient also receiving antifungal medication, demonstrating effective treatment approaches for these unusual infections.

Trichophyton indotineae Infection, São Paulo, Brazil, 2024

mycolabadmin

A businessman from São Paulo, Brazil contracted a difficult-to-treat fungal skin infection caused by Trichophyton indotineae, which is resistant to the common antifungal drug terbinafine. After terbinafine failed to help over 9 weeks, doctors switched him to itraconazole, which worked well after 8 weeks. Genetic testing showed his fungal strain had a specific resistance mutation and was most similar to a strain from Germany, suggesting he may have caught it while traveling in Europe.

Genome characterization of Trichophyton mentagrophytes genotype VII strain PG12DES from Italy

mycolabadmin

Researchers in Italy analyzed the genetic makeup of a fungus called Trichophyton mentagrophytes that causes skin infections and appears to spread between people through sexual contact. The fungal strain studied was susceptible to all tested antifungal medications and shared similarities with a strain previously found in Moldova. This study helps doctors understand how this emerging fungal infection spreads globally and whether it’s developing resistance to treatments.

Diagnostic Performance of a PCR-Based Approach for the Diagnosis of Dermatomycosis

mycolabadmin

This study evaluated a new testing method combining DNA analysis (PCR) with traditional microscopy and culture to diagnose fungal skin, hair, and nail infections. The PCR method detects the infection quickly and accurately, identifying the specific fungus causing the problem within days rather than weeks. The study of over 4,400 samples found that Trichophyton rubrum was the most common cause of fungal infections, and the combined testing approach was 98.5% accurate while reducing unnecessary lab work.

Research Topic: Medical Mycology